| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.91B | 35.48B | 36.95B | 35.24B | 31.10B | 32.19B |
| Gross Profit | 23.95B | 21.73B | 23.01B | 22.82B | 20.07B | 21.08B |
| EBITDA | -641.00M | 2.31B | -76.00M | -1.11B | 2.90B | -743.00M |
| Net Income | -1.89B | 530.00M | -1.47B | -2.17B | 748.00M | -1.81B |
Balance Sheet | ||||||
| Total Assets | 22.13B | 18.99B | 20.32B | 22.53B | 24.28B | 24.64B |
| Cash, Cash Equivalents and Short-Term Investments | 5.08B | 6.70B | 4.66B | 5.57B | 7.07B | 5.32B |
| Total Debt | 6.30B | 5.38B | 6.24B | 6.24B | 7.10B | 7.15B |
| Total Liabilities | 15.08B | 11.68B | 13.55B | 14.31B | 13.89B | 14.12B |
| Stockholders Equity | 7.05B | 7.30B | 6.76B | 8.22B | 10.38B | 10.52B |
Cash Flow | ||||||
| Free Cash Flow | 2.30B | -1.56B | -1.01B | -1.29B | 1.35B | -1.34B |
| Operating Cash Flow | 2.30B | -782.00M | 944.00M | 1.19B | 1.53B | -1.26B |
| Investing Cash Flow | 0.00 | 3.75B | -1.86B | -1.74B | 884.00M | 116.00M |
| Financing Cash Flow | 0.00 | -914.00M | 1.00M | -949.00M | -666.00M | 826.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥50.56B | 10.68 | ― | 2.41% | 6.49% | 4.27% | |
70 Outperform | ¥128.12B | 28.18 | ― | 0.70% | 5.15% | 47.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥77.76B | 113.87 | ― | 0.32% | 0.51% | 4.92% | |
58 Neutral | ¥143.16B | 39.79 | ― | 0.63% | 4.32% | 11.78% | |
57 Neutral | ¥108.24B | 32.58 | ― | 0.37% | 20.44% | 13.71% | |
41 Neutral | ¥119.14B | 197.93 | ― | ― | -12.01% | ― |